News

green ribbon

High demand for cofund NI investment in second quarter of 2022

Congratulations to portfolio company, Sonraí Analytics Ltd, for securing its 'Seed Plus' round with new lead investor Forward Partners.

Exciting times ahead for this company as it seeks to reach more companies globally to translate precision medicine’s complex multi-omics data into real insights leading to better-personalised treatments for patients.

Sonrai Analytics, an emerging global innovator in AI Cloud Data Analytics, today announced a ‘seed plus’ funding round of £2.175 million to accelerate the global adoption of its technology. The investment will help Sonrai reach more companies globally to translate precision medicine’s complex multi-omics data into real insights leading to better-personalised treatments for patients.

The funding round was led by Forward Partners, a leading venture capital firm in London specialising in the tech sector. Existing institutional investors Techstart Ventures, Co-Fund NI (managed by Clarendon Fund Managers), QUBIS, and Angel Investors also participated in the round.

Luke Smith, Investment Partner at Forward Partners said: “We’re delighted to back Sonrai on the next stage of their growth to become a leading precision medicine platform. At Forward, we’re excited by companies that apply cutting-edge AI to solve big problems and make new discoveries. We’ve been really impressed by the strength of Sonrai’s platform and the ability to combine multiple types of healthcare data to gain insights into patients’ health. We see the great potential it holds to accelerate new drug and healthcare developments. Darragh’s expertise in the space has enabled him to build a very strong team and impressive traction with customers for a business of this stage.”